Arteriosclerosis, Thrombosis, Vascular Biology

Science News

Subclinical and Device Detected Atrial Fibrillation Pondering the Knowledge Gap
Interventional Therapies for Acute Pulmonary Embolism
Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing
Omega 3 Fatty Acids for the Management of Hypertriglyceridemia
2019 CVD Primary Prevention Guideline

Continuing Education

Several healthcare professionals wearing masks, standing together facing camera.

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


PVD Council members are focused on improving the care of patients with vascular diseases by advancing science, education, advocacy, and improved healthcare delivery. Members support the AHA mission through active involvement in the council’s scientific initiatives and educational programs, including the annual Scientific Sessions and Vascular Discovery meetings.


SOLOIST WHF and SCORED Results

Investigator Deepak Bhatt, MD summarizes the results of 2 trials on dual SGT1 and SGT2 inhibition, which he presented during Scientific Sessions 2020.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses